Plain-English translation of NCT07065240 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This research study is testing a new medication called to see if it can help treat major depression, whether or not you also experience anxiety. About 360 adults will participate, with half receiving the medication and half receiving a placebo (a pill with no active ingredient) once daily for 6 weeks. Researchers will compare how well the medication works compared to placebo and track how safe it is.
Depression is a serious condition that doesn't always respond well to existing treatments, and many people experience anxiety alongside their depression. This study is exploring whether this medication could offer a new treatment option for people who need better solutions for managing these conditions.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will take one capsule by mouth once each day for 42 days (6 weeks). Half of participants will receive and half will receive placebo, assigned randomly — neither you nor the research team will know which you're getting. You'll need to complete study visits where researchers will check on your symptoms, mood, and any side effects you may experience.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
United States